Paul Tudor Jones profile

Paul Tudor Jones | Tudor Investment Corp Et Al

Fund Stats for Q3 2019Paul Tudor Jones is the managing partner of Tudor Investment Corp Et Al. The 13F filing for 2019 Q3 included $2.91B in managed 13F securities and a top 10 holdings concentration of 28.04%. Tudor Inves...

About Paul Tudor JonesPaul Tudor Jones II, founder and chief investment officer of Boston-based Tudor Investment Group, is one of the pioneers of the modern-day hedge fund industry. Jones began his career in the cotton pit...

Company
Ticker
Market Value
% Portfolio
Shares
Change
Chg. Shares
Quarter End Price
Current Price
Yearly High
Yearly Low
Market Cap
% Owned
SPY
215.36M
7.39%
725.70K
-68.35%
-1.57M
$296.76
$390.12
$479.98
$362.17
358.05B
0.08%
128.35M
4.40%
1.29M
15.35%
172K
$99.30
120.27M
4.13%
1.75M
67.53%
704.64K
$68.80
94.50M
3.24%
561.50K
112.76%
297.58K
$168.29
SPY
67.17M
2.31%
226.34K
New
226.34K
$296.77
$390.12
$479.98
$362.17
358.05B
0.02%
44.05M
1.51%
443.60K
-9.84%
-48.40K
$99.30
DIS
42.87M
1.47%
328.98K
21.67%
58.59K
$130.32
$110.77
$185.9
$90.23
201.94B
0.02%
MSFT
38.92M
1.34%
279.92K
9.38%
24.00K
$139.03
$245.38
$349.67
$241.51
1.88T
0.00%
SPY
37.36M
1.28%
125.90K
-69.88%
-292.10K
$296.75
$390.12
$479.98
$362.17
358.05B
0.01%
28.35M
0.97%
1.50M
New
1.50M
$18.86
22.24M
0.76%
1.63M
New
1.63M
$13.63
21.04M
0.72%
1.12M
New
1.12M
$18.86
AMZN
19.25M
0.66%
11.09K
47.47%
3.57K
$1,735.93
$126.28
$188.1075
$101.26
1.29T
0.00%
NOW
19.04M
0.65%
74.99K
87.06%
34.90K
$253.85
$435.55
$707.6
$406.47
87.98B
0.04%
AYX
18.99M
0.65%
176.79K
183.96%
114.53K
$107.43
$66.81
$81.3
$43.45
4.58B
0.26%
TIP
17.48M
0.60%
150.35K
-2.73%
-4.22K
$116.29
$110.16
$131.37
$110.07
19.58B
0.08%
ORCL
16.61M
0.57%
301.77K
189.34%
197.48K
$55.03
$70.24
$106.34
$63.76
189.34B
0.01%
UNH
15.02M
0.52%
69.11K
216.01%
47.24K
$217.32
$522.91
$553.29
$383.12
489.12B
0.01%
PSA
14.94M
0.51%
60.93K
New
60.93K
$245.27
$313.66
$421.76
$292.32
55.21B
0.03%
SBUX
14.92M
0.51%
168.78K
New
168.78K
$88.42
$92.22
$117.8
$68.39
105.81B
0.01%

Holdings Breakdown

Legend
SPY
Celgene Corporation
Suntrust Banks Inc
Allergan Plc
SPY
Celgene Corporation
DIS
MSFT
SPY
Alder Biopharmaceuticals Inc
United Financial Bancorp Inc/new
Alder Biopharmaceuticals Inc
AMZN
NOW
AYX
TIP
ORCL
UNH
PSA
Other
Disclaimer: Investor holdings are derived from 13F filings which are required to be filed by all institutional investment managers with at least $100 million in assets under management. Limitations to this data include but are not limited to: (1) SEC does not review 13Fs for accuracy or completeness, (2) cash, foreign stocks, short positions, and a variety of other assets are not required to be reported, (3) 13Fs are often filed 45 days after the end of the quarter, by which time a manager's positions and outlook could have changed significantly, (4) the market value does not tell us at what price the manager acquired the asset, and (5) data is only available starting mid 2013. Please do your own research before drawing any conclusions from this data.